For procurement managers and R&D scientists in the pharmaceutical sector, sourcing high-quality pharmaceutical intermediates is a critical task. The integrity and efficacy of the final drug product directly depend on the purity and consistency of the raw materials. One such vital intermediate is (R)-3-Amino-4-(2-trifluoromethyl-phenyl)-butyric acid Hydrochloride (CAS: 269396-76-1), a specialized chiral amino acid derivative.

When making purchase decisions for compounds like this, several criteria must be met. Firstly, the supplier must demonstrate a commitment to stringent quality control. This includes providing detailed certificates of analysis (CoA) confirming purity levels, such as the 97% purity offered for this particular product. Secondly, reliability of supply is paramount. Pharmaceutical R&D timelines are often tight, and stock-outs can cause significant delays. Therefore, partnering with manufacturers who have robust production capabilities and stable supply chains is essential. Many leading suppliers in China offer excellent production capacity and logistical networks.

The specific chemical structure of (R)-3-Amino-4-(2-trifluoromethyl-phenyl)-butyric acid Hydrochloride makes it particularly valuable. As a chiral building block, it is instrumental in the stereoselective synthesis of complex active pharmaceutical ingredients (APIs). The presence of the trifluoromethyl group further enhances its utility by influencing lipophilicity and metabolic stability, properties crucial for effective drug delivery and action. By choosing to buy from reputable manufacturers, you ensure that these beneficial attributes are consistently delivered.

We, as a dedicated manufacturer and supplier, understand these critical needs. We are committed to providing pharmaceutical professionals with access to high-purity, reliable intermediates like (R)-3-Amino-4-(2-trifluoromethyl-phenyl)-butyric acid Hydrochloride. We encourage you to request a quote or sample to experience the quality and service we offer. Secure your supply chain and accelerate your drug development by partnering with us.